知镜 Cognispect · 医学文献与研究工作台

Epidemiology and outcomes in pediatric neuroblastoma: a US population-based study.

Wadhwani S, Wadhwani N, Nagesh VK, Aguilar IK, Amoozgar B, Avvari S, Sridharan KS, Siddiqui A, Sharma U, Velichko O, Baek K, Auda A, Baldeo VO, Bhavsar T, Souza G, Antaal H, Furman F, Rokade P, Mondal G, Vaddera PT, Bhagavathi D, Nazly S, Papantoniou D, John G, Aruljothi DK, Radhakrishnan R, Dongre JV.
Frontiers in medicine · 2026-10-15 · PMID 42959091

文献摘要

Purpose Neuroblastoma is a heterogeneous pediatric malignancy with variable outcomes. This study aimed to evaluate survival outcomes and identify independent prognostic factors using a large population-based cohort. Methods The Surveillance, Epidemiology, and End Results (SEER) database was used to identify 863 patients diagnosed with neuroblastoma between 2000 and 2017. Multivariable Cox proportional hazards regression was performed to assess predictors of overall and cancer-specific mortality. Results The cohort included nearly equal numbers of males and females, with most patients diagnosed before 10 years of age. The majority of patients were non-Hispanic White, followed by Hispanic and non-Hispanic African American patients. In univariate analysis, race/ethnicity showed differences in mortality; however, these were not significant after multivariable adjustment. Increasing age at diagnosis was strongly associated with worse survival, with infants ( Conclusion Age at diagnosis and disease stage are the strongest independent predictors of survival in pediatric neuroblastoma. Race/ethnicity was not independently associated with outcomes after adjustment. Observed associations between chemotherapy and mortality likely reflect underlying disease severity rather than treatment effect.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。